{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:48:01Z","timestamp":1791330481798,"version":"4.3.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.braindev.2011.08.007","type":"journal-article","created":{"date-parts":[[2011,9,7]],"date-time":"2011-09-07T02:35:00Z","timestamp":1315362900000},"page":"344-348","source":"Crossref","is-referenced-by-count":30,"title":["Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy"],"prefix":"10.1016","volume":"34","author":[{"given":"Hee","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Chan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hee","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Seung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2011.08.007_b0005","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1528-1157.2001.31400.x","article-title":"Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study. Coordination Active du R\u00e9seau Observatoire Longitudinal de l\u2019 Epilepsie","volume":"42","author":"Jallon","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2011.08.007_b0010","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1528-1157.2000.tb04604.x","article-title":"How well can epilepsy syndromes be identified at diagnosis? A reassessment 2 years after initial diagnosis","volume":"41","author":"Berg","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2011.08.007_b0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2011.08.007_b0020","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1111\/j.1528-1157.1996.tb06020.x","article-title":"Pediatric epilepsy syndromes: an update and critical review","volume":"37","author":"Duchowny","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2011.08.007_b0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.seizure.2004.12.003","article-title":"A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine","volume":"14","author":"Posner","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2011.08.007_b0030","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1469-8749.1982.tb13703.x","article-title":"Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal)","volume":"24","author":"Callaghan","year":"1982","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2011.08.007_b0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1212\/WNL.32.2.157","article-title":"Valproic acid versus ethosuximide in the treatment of absence seizures","volume":"32","author":"Sato","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2011.08.007_b0040","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa0902014","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy","volume":"362","author":"Glauser","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2011.08.007_b0045","unstructured":"Loiseau J, Panayiotopoulos P. Childhood absence epilepsy [Internet]. 2000. Available from: http:\/\/www.ilae-epilepsy.org\/ctf\/childhood_absence.html [updated 2002 November 5; cited 2010 December 2]."},{"key":"10.1016\/j.braindev.2011.08.007_b0050","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.braindev.2010.02.004","article-title":"Childhood absence epilepsy: elctroclinical features and diagnostic criteria","volume":"33","author":"Ma","year":"2011","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2011.08.007_b0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1212\/01.wnl.0000228257.60184.82","article-title":"Electroclinical features of absence seizures in childhood absence epilepsy","volume":"67","author":"Sadleir","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2011.08.007_b0060","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1111\/j.1528-1167.2005.00277.x","article-title":"Childhood absence epilepsy: evolution and prognostic factors","volume":"46","author":"Grosso","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2011.08.007_b0065","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.0013-9580.2004.40903.x","article-title":"Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study","volume":"45","author":"Coppola","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2011.08.007_b0070","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1528-1167.2005.00322.x","article-title":"Management guidelines for children with idiopathic generalized epilepsy","volume":"46","author":"Camfield","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2011.08.007_b0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eplepsyres.2008.11.011","article-title":"Long-term outcome of childhood absence epilepsy: dutch study of epilepsy in childhood","volume":"83","author":"Callenbach","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2011.08.007_b0080","first-page":"357","article-title":"Lamictal (lamotrigine) monotherapy for typical absence seizures in children","volume":"41","author":"Frank","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2011.08.007_b0085","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2011.08.007_b0090","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/09513590802288259","article-title":"Polycystic ovary syndrome in women using valproate: a review","volume":"24","author":"Bilo","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.braindev.2011.08.007_b0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0387-7604(03)00090-1","article-title":"Lamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological study","volume":"26","author":"Coppola","year":"2004","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2011.08.007_b0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eplepsyres.2008.07.016","article-title":"Lamotrigine monotherapy for newly diagnosed typical absence seizures in children","volume":"82","author":"Holmes","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2011.08.007_b0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/00128072-200103050-00006","article-title":"Treatment of typical absence seizures and related epileptic syndromes","volume":"3","author":"Panayiotopoulos","year":"2001","journal-title":"Paediatr Drugs"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760411002178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760411002178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T02:25:37Z","timestamp":1543544737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760411002178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0387760411002178"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2011.08.007","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}